B

Badruzzamanadeem

Director Director DIN 07785488
DIN 07785488 First appointment Apr 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Badruzzamanadeem

Data last updated:

Badruzzamanadeem was a Director at Vello Healthcare Private Limited (2024) and Director at Acukart Online Private Limited (from 2017).

DIN 07785488
Primary Designation Director
First Appointment 10 Apr 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vello Healthcare Private Limited U86201KA2024PTC187507
Director16 Apr 20242024Active
Acukart Online Private Limited U52609KA2017PTC102123
Director10 Apr 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acukart Online Private Limited
Vello Healthcare Private Limited
Premium access

Shareholding and investment profile for Badruzzamanadeem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Badruzzamanadeem

Badruzzamanadeem was first appointed on 10 Apr 2017 as Director at Acukart Online Private Limited. The most recent appointment on record is 16 Apr 2024 at Vello Healthcare Private Limited.

Badruzzamanadeem held 2 earlier board appointments: Vello Healthcare Private Limited (Director, 16 Apr 2024 to 26 Aug 2024); Acukart Online Private Limited (Director, from 10 Apr 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available